Betrixaban
- Generic Name
- Betrixaban
- Brand Names
- BEVYXXA
- Drug Type
- Small Molecule
- Chemical Formula
- C23H22ClN5O3
- CAS Number
- 330942-05-7
- Unique Ingredient Identifier
- 74RWP7W0J9
- Background
Betrixaban is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa . It was selected among all lead compounds due to its low hERG channel affinity while sustaining its factor Xa inhibition capacity . Betrixaban, now developed by Portola Pharmaceuticals Inc., is prescribed as a venous thromboe...
- Indication
Betrixaban is indicated for prophylaxis of venous thromboembolism (VTE) in conditions of moderate to severe restricted mobility or in patients that qualify as in risk of VTE.
- Associated Conditions
- Venous Thromboembolism
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath